Prevention of Seasonal Affective Disorder

June 2, 2015 updated by: GlaxoSmithKline
A Placebo Controlled Study Evaluating The Effectivess Of Medication In Preventing Seasonal Affective Disorder

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Interventional

Phase

  • Phase 3

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Canada
    • Alberta
      • Edmonton, Alberta, Canada, T6G 2C8
        • Study Site
    • British Columbia
      • Vancouver, British Columbia, Canada, V6Z 1Y6
        • Study Site
    • New Brunswick
      • Miramichi, New Brunswick, Canada, E1V 3G5
        • Study Site
    • Nova Scotia
      • Sydney, Nova Scotia, Canada, B1S 2E8
        • Study Site
    • Ontario
      • Markham, Ontario, Canada, L6B 1A1
        • Study Site
      • Mississauga, Ontario, Canada, L4W 1N2
        • Study Site
    • Quebec
      • Hull, Quebec, Canada, J9A 1K7
        • Study Site
  • United States
    • Alaska
      • Homer, Alaska, United States, 99603
        • Study Site
    • Connecticut
      • New Haven, Connecticut, United States, 06504-0605
        • Study Site
    • Delaware
      • Newark, Delaware, United States, 19713
        • Study Site
      • Wilmington, Delaware, United States, 19808-1251
        • Study Site
    • District of Columbia
      • Washington, District of Columbia, United States, 20016
        • Study Site
      • Washington, District of Columbia, United States, 20037
        • Study Site
    • Idaho
      • Boise, Idaho, United States, 83704
        • Study Site
    • Illinois
      • Chicago, Illinois, United States, 60610
        • Study Site
      • Chicago, Illinois, United States, 60612
        • Study Site
      • Hoffman Estates, Illinois, United States, 60194
        • Study Site
      • Libertyville, Illinois, United States, 60048
        • Study Site
      • Northfield, Illinois, United States, 60093
        • Study Site
      • Schaumburg, Illinois, United States, 60194
        • Study Site
    • Indiana
      • Greenwood, Indiana, United States, 46143
        • Study Site
      • Indianapolis, Indiana, United States, 45202
        • Study Site
    • Kentucky
      • Florence, Kentucky, United States, 41042
        • Study Site
    • Massachusetts
      • Wellesley Hills, Massachusetts, United States, 02481
        • Study Site
    • Michigan
      • Okemos, Michigan, United States, 48864
        • Study Site
      • Royal Oak, Michigan, United States, 48067
        • Study Site
    • Minnesota
      • Minneapolis, Minnesota, United States, 55454
        • Study Site
    • New Jersey
      • Moorestown, New Jersey, United States, 08057
        • Study Site
      • Piscataway, New Jersey, United States, 08854
        • Study Site
    • New York
      • Amityville, New York, United States, 11701
        • Study Site
      • Lawrence, New York, United States, 11559
        • Study Site
      • New York, New York, United States, 10021
        • Study Site
      • Olean, New York, United States, 14760
        • Study Site
      • Staten Island, New York, United States, 10305
        • Study Site
      • Williamsville, New York, United States, 14221
        • Study Site
    • Ohio
      • Cincinnati, Ohio, United States, 45219
        • Study Site
      • Cleveland, Ohio, United States, 44106
        • Study Site
      • Cleveland, Ohio, United States, 44121
        • Study Site
      • Independence, Ohio, United States, 44131
        • Study Site
      • Lyndhurst, Ohio, United States, 44124
        • Study Site
      • Toledo, Ohio, United States, 43623
        • Study Site
    • Oregon
      • Eugene, Oregon, United States, 97401
        • Study Site
      • Portland, Oregon, United States, 97201
        • Study Site
      • Portland, Oregon, United States, 97209
        • Study Site
      • Salem, Oregon, United States, 97309
        • Study Site
    • Pennsylvania
      • Allentown, Pennsylvania, United States, 18104
        • Study Site
      • Philadelphia, Pennsylvania, United States, 19106
        • Study Site
      • Philadelphia, Pennsylvania, United States, 19107
        • Study Site
    • Rhode Island
      • Lincoln, Rhode Island, United States, 02865-4208
        • Study Site
    • Washington
      • Seattle, Washington, United States, 98104
        • Study Site
    • Wisconsin
      • Madison, Wisconsin, United States, 53719
        • Study Site
      • Middleton, Wisconsin, United States, 53562
        • Study Site
      • Milwaukee, Wisconsin, United States, 53226
        • Study Site
      • West Allis, Wisconsin, United States, 53227
        • Study Site

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria: (Patient must meet these criteria in order to be eligible for this study.)

  • Patient has a history of Major Depressive Disorder (MDD) with a seasonal pattern.

Exclusion Criteria: (Patient cannot meet these criteria in order to be eligible for this study.)

  • Patient has a current or past history of seizure disorder or brain injury.
  • Patient has a history or current diagnosis of anorexia nervousa or bulimia.
  • Patient has recurrent summer depression more frequently than winter depression.
  • Patient has primary diagnosis of panic disorder, Obsessive Compulsive Disorder (OCD), Posttraumatic Stress Disorder (PTSD), acute distress disorder, bipolar II disorder or other psychotic disorders.
  • Patient has initiated psychotherapy within the last 3 months.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

GlaxoSmithKline

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

September 1, 2002

Primary Completion (Actual)

June 1, 2003

Study Completion (Actual)

June 1, 2003

Study Registration Dates

First Submitted

September 30, 2002

First Submitted That Met QC Criteria

October 1, 2002

First Posted (Estimate)

October 2, 2002

Study Record Updates

Last Update Posted (Estimate)

June 4, 2015

Last Update Submitted That Met QC Criteria

June 2, 2015

Last Verified

June 1, 2015

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 398149

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Seasonal Affective Disorder (SAD)

Clinical Trials on Investigational Seasonal Affective Disorder (SAD) Drug

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Congo

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe